Prospective study of Quyu Jiedu Prescription for postoperative maintenance therapy in patients with metastatic colorectal cancer

Zhongshan Affiliated Hospital Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Male or female aged 18 years to 80 years old;
•2. Pathologically diagnosed as colorectal adenocarcinoma;
•3. At the time of initial diagnosis, enhanced CT or MRI showed that the clinical stage of colon cancer was stage IV with liver and / or lung metastasis, and R0 resection or radiofrequency ablation was performed on the primary tumor and metastatic lesions. The perioperative chemotherapy was completed, and the CT or MRI examination reached NED(No evidence of disease) within 4 weeks before enrollment.
•4. ECOG PS 0-1
•5. There were no other underlying diseases affecting organ function.
•6. Understand, be willing to give consent, and sign the written informed consent form (ICF) prior to undergoing any study-specific procedure.

•1. Patients diagnosed with more than one malignancy.
•2. Pregnant or lactating women.
•3. Patients with mental illness
•4. Combined with coronary heart disease, myocardial infarction, renal failure, pulmonary embolism and other diseases that may affect the survival of patients
•5. Patients with poor compliance can not cooperate with the treatment.

发起方

Zhongshan Affiliated Hospital Guangzhou University of Chinese Medicine